carbon monoxide has been researched along with Hepatopulmonary Syndrome in 6 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Hepatopulmonary Syndrome: A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
Excerpt | Relevance | Reference |
---|---|---|
"Hepatopulmonary syndrome is defined as the clinical triad of advanced liver disease, arterial deoxygenation and intrapulmonary vascular dilatation." | 2.43 | Recent advances in hepatopulmonary syndrome. ( Lin, HC; Wang, YW, 2005) |
"Higher MELD-Na score, hepatic encephalopathy, impaired DLCO, clubbing, and spider naevi were independently associated with HPS." | 1.56 | Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease. ( Joshi, S; Kanala, JR; Kareem, H; Khiangte, B; Kothakota, SR; Kumar C, P; Kumar, VV; Nair, AK; Sasidharan, M, 2020) |
" After administration of a given dosage of LPS in rats with cirrhosis, various pathological parameters worsened." | 1.33 | Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. ( Han, DW; Wang, XG; Zhang, HY; Zhao, HZ; Zhao, YC; Zhou, X, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Sabang, RL | 1 |
Abu-Hishmeh, M | 1 |
Bodin, R | 1 |
Epelbaum, O | 1 |
Khiangte, B | 1 |
Kothakota, SR | 1 |
Sasidharan, M | 1 |
Kareem, H | 1 |
Joshi, S | 1 |
Kumar, VV | 1 |
Kanala, JR | 1 |
Kumar C, P | 1 |
Nair, AK | 1 |
Carter, EP | 1 |
Hartsfield, CL | 1 |
Miyazono, M | 1 |
Jakkula, M | 1 |
Morris, KG | 1 |
McMurtry, IF | 1 |
Zhang, HY | 1 |
Han, DW | 1 |
Wang, XG | 1 |
Zhao, YC | 1 |
Zhou, X | 1 |
Zhao, HZ | 1 |
Arguedas, MR | 1 |
Drake, BB | 1 |
Kapoor, A | 1 |
Fallon, MB | 1 |
Wang, YW | 1 |
Lin, HC | 1 |
1 review available for carbon monoxide and Hepatopulmonary Syndrome
Article | Year |
---|---|
Recent advances in hepatopulmonary syndrome.
Topics: Carbon Monoxide; Echocardiography; Hepatopulmonary Syndrome; Humans; Nitric Oxide; Prognosis; Techne | 2005 |
5 other studies available for carbon monoxide and Hepatopulmonary Syndrome
Article | Year |
---|---|
Impact of Liver Transplantation on Carbon Monoxide Production as Measured by Arterial Carboxyhemoglobin Levels in Cirrhotic Patients with and without Hepatopulmonary Syndrome.
Topics: Aged; Carbon Monoxide; Carboxyhemoglobin; End Stage Liver Disease; Female; Hepatopulmonary Syndrome; | 2021 |
Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease.
Topics: Carbon Monoxide; Chronic Disease; Cross-Sectional Studies; Female; Hepatic Encephalopathy; Hepatopul | 2020 |
Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome.
Topics: Animals; Blood Pressure; Carbon Monoxide; Common Bile Duct; Enzyme Inhibitors; Heme Oxygenase (Decyc | 2002 |
Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome.
Topics: Acid-Base Imbalance; Acidosis; Animals; Bacterial Translocation; Brain; Carbon Monoxide; Endothelin- | 2005 |
Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome.
Topics: Bilirubin; Carbon Monoxide; Carboxyhemoglobin; Female; Hepatopulmonary Syndrome; Humans; Liver Cirrh | 2005 |